常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
0.98/2.37
|
|
企業價值
4.72B
|
| 資產負債 |
|
每股賬面淨值
-1.66
|
| 現金流量 |
|
現金流量率
0.04
|
| 損益表 |
|
收益
1.09B
|
|
每股收益
8.01
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. |

35.19 
